You are here

Eli Lilly

Eli Lilly wins FDA approval for first-ever treatment for hair loss caused by autoimmunity

Stat

Mon, 06/13/22 - 09:49 pm

alopecia areata

State high court says Eli Lilly warned doctor of drug risks, didn’t need to warn patient

MedCity News

Fri, 06/10/22 - 10:33 am

Innovent catching up with Lilly, Novo Nordisk thanks to phase 2 obesity data

Fierce Biotech

Wed, 06/8/22 - 10:34 am

clinical trials

ADA: Eli Lilly's stellar tirzepatide weight loss data tee up showdown with Novo Nordisk's Wegovy, analysts say

Fierce Pharma

Mon, 06/6/22 - 11:42 pm

tirzepatidem diabetes

State supreme court rules in favor of Eli Lilly in case over warning patients of risks when DTC ads are in play

Endpoints

Sun, 06/5/22 - 11:37 pm

Eli Lilly plots $2.1B manufacturing expansion at America's crossroads, with 500 new hires

Fierce Pharma

Wed, 05/25/22 - 11:40 pm

drug manufacturing

Second trial opens door for Lilly’s mirikizumab in ulcerative colitis

Pharmaforum

Tue, 05/24/22 - 10:45 am

clinical trials

ulcerative colitis

Chasing Lilly and Pfizer, Concert's JAK inhibitor hits high notes in phase 3 alopecia trial

Fierce Biotech

Mon, 05/23/22 - 10:36 am

Concert Pharmaceuticals

clinical trials

alopecia areata

Eli Lilly revs up immunology engine as Olumiant cruises toward coveted alopecia green light

Fierce Pharma

Thu, 05/19/22 - 12:05 pm

Big pharma’s biggest spenders revealed

EP Vantage

Tue, 05/17/22 - 10:29 am

Bristol Myers Squibb

Lilly's highly anticipated diabetes drug Mounjaro wins FDA blessing

Fierce Pharma

Sun, 05/15/22 - 11:07 pm

type 2 diabetes

Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices

Fierce Pharma

Thu, 05/12/22 - 10:54 pm

FDA approves new indication for drug to treat severe COVID-19

Beckers Hospital Review

Thu, 05/12/22 - 10:51 pm

In wake of Biogen's skirmish with the SEC, pharma giants are changing the way they do quarterly reports

Endpoints

Thu, 05/5/22 - 11:34 pm

Bristol Myers Squibb

Genesis and Lilly Ink AI Collab Worth Up to $670M

BioSpace

Tue, 05/3/22 - 10:44 am

Genesis Therapeutics

artificial intelligence

Eli Lilly ends Q1 on a high note on the heels of positive obesity trial data

Endpoints

Thu, 04/28/22 - 10:46 pm

Lilly's tirzepatide clears high bar set by Novo's Wegovy in obesity

Fierce Biotech

Thu, 04/28/22 - 10:53 am

Late-stage pain pipeline refuses to swell

EP Vantage

Tue, 04/26/22 - 10:29 pm

Teva Pharmaceutical

Ampio Pharmaceuticals

Vertex Pharmaceuticals

Acadia Pharmaceuticals

Does Eli Lilly's Future Depend on its Alzheimer's Drug?

Motley Fool

Sat, 04/23/22 - 04:02 pm

Alzheimer's disease

The next battle in the never-ending war over Aduhelm

Stat

Fri, 04/15/22 - 01:50 pm

Alzheimer's disease

Pages